Câncer de rim |
|
Cannabis e saúde mental |
|
The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trials |
|
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain |
|
Effects of pregabalin on behavioral alterations induced by ketamine in rats. |
|
The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study |
|
Electroconvulsive therapy for coexistent schizophrenia and obsessive-compulsive disorder |
|
Endocannabinoid levels in patients with Parkinson's disease with and without levodopa-induced dyskinesias |
|
Ensuring access to safe, effective, and affordable cannabis-based medicines |
|
Entrevista clínica estruturada para os transtornos do DSM-5 : SCID-5-CV : versão clínica |
|
Evaluation of the psychometric properties of the Social Phobia Inventory in university students |
|
Facial emotion processing and recognition among maltreated children: a systematic literature review |
|
Facial emotion processing in patients with social anxiety disorder and Williams-Beuren syndrome: an fMRI study |
|
[Factorial structure of the Brazilian version of the Modified Reasons for Smoking Scale]. |
|
The fast alcohol screening test (FAST) is as good as the AUDIT to screen alcohol use disorders |
|
Further psychometric study of the Beck Anxiety Inventory including factorial analysis and social anxiety disorder screening. |
|
Further study of the psychometric qualities of a brief screening tool for social phobia (MINI-SPIN) applied to clinical and nonclinical samples. |
|
[Guidelines of the Brazilian Medical Association for the treatment of social anxiety disorder] |
|
Higher prevalence of major depressive symptoms in Brazilians aged 14 and older |
|
Increased amygdalar and hippocampal volumes in young adults with social anxiety |
|
Increased body sway in phobic patients exposed to images of spiders |
|
Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. |
|
The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users. |
|
Interaction between cannabidiol (CBD) and ∆(9)-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids |
|
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects |
|
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life |
|
Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms? |
|
Is the Fagerström Test for Nicotine Dependence a good instrument to assess tobacco use in patients with schizophrenia? |
|
Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions |
|
Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning? |
|
Letter to the Editor |
|
Lipoma adhered to the corpus callosum in a schizophrenic patient with severe positive symptoms that responded to clozapine |
|
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. |
|
Marijuana, feijoada and the debate on drug legalization |
|
Mitral valve prolapse and anxiety disorders. |
|
National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health. |
|
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report |
|
Neuroimaging correlates of pharmacological and psychological treatments for specific phobia |
|
Neuroimaging in specific phobia disorder: a systematic review of the literature |
|
Neuroimaging of major depression in Parkinson's disease: Cortical thickness, cortical and subcortical volume, and spectroscopy findings. |
|
New editors and new challenges |
|
NMDA and AMPA/kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by GABAA receptor blockade in the medial hypothalamus. |
|
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. |
|
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol. |
|
Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomy |
|
On museums and scientific journals |
|
Oral Cannabidiol Does Not Convert to Δ8-THC or Δ9-THC in Humans: A Pharmacokinetic Study in Healthy Subjects |
|
Oxytocin interference in the effects induced by inhalation of 7.5% CO(2) in healthy volunteers. |
|
Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness |
|
Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD). |
|
Pharmacotherapy treatment of depression in patients with neurodegenerative diseases: where are we? |
|
Proneness, urbanicity, trauma, and cannabis triggering psychotic states in large urban centers |
|
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network |
|
The psychiatric side-effects of rimonabant |
|
Psychometric properties of the dimensional anxiety scales for DSM-5 in a Brazilian community sample. |
|
Psychometric qualities of the Brazilian versions of the Fagerström Test for Nicotine Dependence and the Heaviness of Smoking Index. |
|
Psychometrics properties of early trauma inventory self report - short form (ETISR-SR) for the Brazilian context |
|
Quality of life in patients with Charcot-Marie-Tooth disease type 1A. |
|
Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial |
|
RBP increases its impact factor again and is progressively more cited in other journals |
|
RBP Psychiatry: the crowning of an editorial policy |
|
Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. |
|
Reprint of "Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)". |
|
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report |
|
Safety and side effects of cannabidiol, a Cannabis sativa constituent |
|
Social anxiety and negative early life events in university students |
|
Social anxiety disorder women easily recognize fearfull, sad and happy faces: the influence of gender |
|
Social phobia in Brazilian university students: prevalence, under-recognition and academic impairment in women. |
|
Structural magnetic resonance imaging in anxiety disorders: an update of research findings |
|
Structured clinical interview for DSM-5 |
|
Sulpiride and refractory panic disorder |
|
Therapeutical use of the cannabinoids in psychiatry |
|
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture. |
|
Trismus induced by fluoxetine. |
|
Validation of the state version of the Self-Statement during Public Speaking Scale. |
|
Validity of the PHQ-2 for the screening of major depression in Parkinson's disease: two questions and one important answer. |
|
Why should Cannabis be Considered Doping in Sports? |
|
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol |
|
সম্পাদককে চিঠি |
|